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Myelination of axons by oligodendrocytes in the central nervous system is essential for
normal neuronal functions.The failure of remyelination due to injury or pathological insults
results in devastating demyelinating diseases. Oligodendrocytes originate in restricted
regions of the embryonic ventral neural tube. After migration to populate all areas of the
brain and spinal cord, oligodendrocyte precursors undergo a temporally well-deﬁned series
of molecular and structural changes, ultimately culminating in the cessation of prolifera-
tion, and the elaboration of a highly complex myelin sheath.The emergence of microRNAs
(miRNAs) as potent regulators of gene expression at the posttranscriptional level has broad
implications in all facets of cell biology. Recent studies have demonstrated a critical role
of miRNAs in oligodendrocyte development, including cell proliferation, differentiation, and
myelin formation. In this review, we will highlight and discuss the recent understanding
of functional links of miRNAs to regulatory networks for central myelination, as well as
perspectives on the role of miRNAs in demyelinating diseases.
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INTRODUCTION
Oligodendrocytes (OLs) produce myelin sheaths that enwrap the
internodal segments of axons to allow axonal insulation and salta-
tory conduction of action potentials in the vertebrate nervous
system.DuringCNS development,OLs arise after successive stages
of lineage progression from OL precursors (OPCs) to imma-
ture OLs and ﬁnally to mature myelinating OLs (Pfeiffer et al.,
1993). This complex process initiates during embryonic devel-
opment and continues into young adult life. It is regulated by
extracellular signals and a network of intrinsic/intracellular fac-
tors with coordinated action in a spatially and temporally speciﬁc
manner. Abnormal development and/or maintenance of myelin
sheaths impairs propagation of action potential along nerve ﬁbers,
leading to nerve degeneration associated with acquired and inher-
ited disorders including devastating multiple sclerosis (MS) and
leukodystrophies (Trapp et al., 1998; Franklin, 2002; Mar and
Noetzel, 2010).
During oligodendrocyte lineage progression, positive regu-
lators are typically induced, whereas negative regulators are
downregulated. This balance of positive and negative regu-
latory circuitry likely controls the differentiation timing of
myelinating cells. A cohort of spatiotemporally speciﬁc fac-
tors that promote OL differentiation including Olig1/2, Sox10,
YY1, Nkx2.2, Zfp488, MRF, and Zfp191 have been shown
to (Xin et al., 2005; Wang et al., 2006; He et al., 2007; Li
et al., 2007; Emery et al., 2009; Howng et al., 2010; Kus-
pert et al., 2011) and coordinate and balance inhibitory sig-
naling pathways such as BMP, Wnt, and Notch signaling
(Grinspan et al., 2000; Mekki-Dauriac et al., 2002; See et al.,
2004; Fu et al., 2009; Emery, 2010). These inhibitory signal-
ing pathways mediate through speciﬁc downstream effectors
such as BMP/Smads, Wnt/β-catenin, Notch/Hes factors, ID2/4,
Sox5/6, and NF1a/b at different developmental stages to inhibit
oligodendrocyte differentiation and myelination (Grinspan et al.,
2000; Mekki-Dauriac et al., 2002; See et al., 2004; Fu et al., 2009;
Emery, 2010).
MicroRNAs (miRNAs) are emerging as important regulators
of various aspects of CNS development by modulating, mainly
downregulating, expression of extrinsic and intrinsic effectors, and
activities of signaling networks in speciﬁc cell types and thereby,
control fate speciﬁcation, and differentiation of neural stem cells
(Shi et al., 2010) and neurogenic niches (Brett et al., 2011).
In this review we summarize and discuss recent ﬁndings of
miRNAs in regulating differentiation of myelinating cells in the
CNS, with a focus on how speciﬁc miRNAs integrate into regu-
latory circuitries to control OL development in physiological and
pathological conditions.
miRNA BIOGENESIS, EXPRESSION, AND FUNCTION
MicroRNAs are short 20–25 nt non-coding RNAs processed from
endogenous genomic loci that bind primarily to the 3′ untrans-
lated region (UTR) of target mRNAs through an imperfect match
to repress their translation and stability (Bartel, 2009). Like tran-
scriptional regulators, miRNAs can cause large-scale changes in
the proteome of a cell, thus regulating nearly every single process
of development and disease (Bartel, 2009; Liu and Olson, 2010;Vo
et al., 2010).
The biogenesis of miRNAs is tightly regulated in a spatially
and temporally controlled manner and responds to environmen-
tal cues and cellular states (Figure 1). miRNAs are transcribed in
most cases byRNApolymerase II to primaryprecursors transcripts
(pri-miRNAs) that are ﬁrst processed in the nucleus byDrosha and
its cofactor DiGeorge syndrome critical region gene 8 (DGCR8)
into an 60–100 hairpin intermediate form (pre-miRNAs). The
pre-miRNAs are then transported by the exportin 5-Ran GTPase
shuttle system into the cytoplasm, where they are further cleaved
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FIGURE 1 | Biosynthesis of miRNAs.The miRNA gene is transcribed by
RNA polymerase II as pri-miRNAs which are then processed by Drosha to
produce long miRNA precursor (pre-miRNA). The pre-miRNAs are
transported to the cytoplasm where they are further cleaved by the
endoribonuclease Dicer to mature ∼22nt long miRNA–miRNA *duplex. In
this process Dicer interacts with theTRBP, PACT, and Argonaute proteins,
which form the RNA-induced silencing complex (RISC).Within this
complex, one strand of the miRNA duplex is removed and the single
stranded miRNA, complementary to the target mRNA, remains in the
complex and becomes functional. Seven to eight base pair “seed”
sequence in 5′ miRNAs is partially complementary to the 3 UTR of mRNA
targets, and induces posttranscriptional silencing through mechanisms
such as mRNA destabilization and translational repression.
by Dicer, an RNase III-like endonuclease to yield mature miR-
NAs (Figure 1). miRNAs are also produced by two non-canonical,
Drosha- or Dicer-dependent pathways. In the ﬁrst pathway, the
early processing step is done by spliceosome and by a debranch-
ing enzyme that yields a short hairpin that is ready for further
processing by Dicer. These non-canonical miRNAs have been
termed mirtrons (Cheng et al., 2007; Ruby et al., 2007). In the
second pathway, short hairpin RNAs (shRNAs) are processed by
unknownnucleases intopre-microRNAs and are further processed
into miRNAs by Dicer. miRNAs that are derived in this way have
been termed endogenous shRNA-derived miRNAs (Babiarz et al.,
2008). Additionally, recent studies describe a few miRNAs that are
processed in a Drosha independent manner (Han et al., 2009),
whereas other miRNAs appear to be Dicer1 independent (Cao
et al., 2009; Chong et al., 2010).
The mature miRNAs are then incorporated into the RNA-
induced silencing complex (RISC), which contains an Argonaute-
subfamily member, that then targets the 3′ UTR region of the
target mRNAs by an imperfect match between the miRNA and
the mRNA, to induce posttranscriptional gene silencing mainly
through mRNA destabilization (Guo et al., 2010; Figure 1). A
short “seed” sequence complementarity in 5′ miRNA (position 2–
8) allows a single miRNA to pair with the 3′UTR of hundreds of
mRNAs (Bartel, 2009). To add a level of complexity, miRNAs are
also found to recognize seedless sites, 5′UTRs, and coding regions
of mRNAs (Asirvatham et al., 2008; Tay et al., 2008; Lal et al.,
2009). Although a majority of regulatory miRNAs appears to have
a negative regulatory role, there are a few cases of miRNAs that
can activate translation of target mRNAs (Vasudevan et al., 2007;
Schwartz et al., 2008).
MicroRNAs are shown to widely participate in neurogene-
sis, including cell fate determination, neural patterning, synaptic
plasticity, activity-dependent regulation, and neurological diseases
(Kosik, 2006; Vo et al., 2010; Zhao et al., 2010), however its role
in OL development is still is still in its infancy. Recently, OL
development and miRNA ﬁelds have converged with the iden-
tiﬁcation of OL-highly enriched miRNAs that are required for OL
differentiation.
DYNAMIC EXPRESSION OF miRNAs DURING
OLIGODENDROCYTE DEVELOPMENT
MicroRNA expression proﬁling analysis of the oligodendrocyte
lineage performed in rodents and in oligodendroglial cells derived
from human ES cells (Lau et al., 2008; Letzen et al., 2010) reveals
a cohort of miRNAs whose expression dynamically changes dur-
ing the differentiation process. Although a few miRNAs in these
two microarray screens are common, the majority of them are
not overlapping at the same developmental stage, which might be
due to the different cell sources or stages used (rat and human).
However, the top twenty miRNAs showing highest expression in
rat OPCs, such as miR-130a, miR-7, miR-16, miR-17, and miR-
20a, are also highly expressed inhuman glial progenitors. Similarly,
miR-17, miR-20a, miR-21, miR-16, miR-103, and miR-107 iden-
tiﬁed in rat premyelinating OL showed overlapping expression
with the human OPCs (Lau et al., 2008; Letzen et al., 2010). Cur-
rently the functions of these miRNAs in OL development remain
elusive.
Interestingly, some miRNAs, such as miR-205, exhibit a high
level of expression in human embryonic stem cells and early neural
progenitor stages,while they are downregulated during earlyOPCs
transition. However, their expression level becomes upregulated
again during mid to late OPC differentiation (Letzen et al., 2010).
This dynamic expression of miRNAs reﬂects the complexity of
miRNAs during differentiation, suggesting that miRNAsmay have
unrelated roles at various stages of lineage development. Specif-
ically, miR-205 contains a conserved 8mer complementary site
within the Cldn11 3’-UTR, encoding for a transmembrane pro-
tein Claudin-11 critical for tight junction formation in the myelin
sheath (Gow et al., 1999; Bronstein et al., 2000).
Another miRNA, miR-199a-5p increases in early OPCs
derived from human ES cells and displays a strong target bias
toward C11Orf9 (Figure 2). miR-199a-5p has three sites with
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FIGURE 2 | miRNAs function at multiple stages to control
oligodendrocyte differentiation and myelination. Speciﬁc miRNAs
involved in regulating the neural precursor to OPC transition, OPC
differentiation, OL maturation and myelination as well as the documented
and predicted targets of those miRNAs are shown. miR-9, miR-214, and
miR-199a-5p are highly expressed in OPCs and prevent premature
differentiation by blocking expression of myelin components including
Mobp, PMP22 and maturation promoting factors such as MRF/C11orf9.
miR-138, -219 and -338 are more highly expressed in OLs and promote OL
differentiation by inhibiting expression of differentiation inhibitors (e.g.,
Hes5, Sox6, and Sox4) and proliferation signaling molecules such as
PDGFRα and FGFR, as well as neuronal differentiation factors (e.g., Zfp238
and FoxJ3). miR-219 may also regulate OL terminal maturation and myelin
maintenance by targeting fatty acid elongases such as Elvol7. The
expression pattern of miRNAs is likely correlated to their functions at
different stages of OL lineage progression.
evolutionarily conserved 8mer seed matches to the 3’ UTR of
C11Orf9, suggesting a high probability for miRNA–mRNA inter-
actions. This gene,C11Orf, is speculated to be the human ortholog
to the mouse MRF, a protein that has been shown to be critical for
oligodendrocyte maturation andmyelin production (Emery et al.,
2009). Thus, it is possible that the downregulation in miR-199a-
5p expression may be concomitant with the initiation of MBP
expression.
miR-214 is highly expressed in rat OPCs but undetectable in
OLs. It has a strong evolutionarily conserved 8mer target site to
Mobp, which is important for providing proper structural prop-
erties of myelin (Letzen et al., 2010; Figure 2), suggesting that
miR-214 might block myelin sheath formation.
Other miRNAs may function to maintain myelin structure.
miR-23 is a negative regulator of lamin B1 (Lin and Fu, 2009).
Excessive Lamin B1 expression has been shown to cause severe
CNSmyelin loss in adult-onset autosomal dominant leukodystro-
phy patients by repressing production of myelin proteins such as
MBP, PLP, and MOG. This suggests that miRNAs such as miR-23
could play an important role in myelin maintenance (Lin and Fu,
2009).
In general, mRNAs exhibit a high degree of stage and tissue
speciﬁcity. The expression proﬁle of miRNAs strictly depends on
the differentiation program occurring. As consequence, miRNAs
in the control of OL fate speciﬁcation are still largely unknown at
present and warrant further investigation.
miRNAs IN NEURAL AND GLIAL SPECIFICATION
Deletion of miRNA-processing enzymeDicer in neural progenitor
cells was found to control the switch of neurogenesis to gliogenesis
(Kawase-Koga et al., 2009; Zheng et al., 2010). A series of evidence
indicate that miRNAs play critical roles in neuronal and astroglial
cell fate decision.
One of themost highly expressingmiRNAs in theCNS that reg-
ulates neural/glial speciﬁcation is miR-124. During neurogenesis,
miR-124 is undetectable or expressed at low levels in progeni-
tor cells and is upregulated in differentiating and mature neurons
(Deo et al., 2006). Overexpression of the neurogenic miR-124 in
HeLa cells represses expression of many non-neuronal genes, and
activates a gene expression program more similar to that of neu-
ronal cells (Lim et al., 2005). Although inhibiting miR-124 did
not affect neuronal differentiation, at least in chick neural tube
(Cao et al., 2007), more recently, miR-124 was shown to promote
neuronal differentiation and cell cycle exit of neural stem cells in
the subventricular zone, one of the neurogenic niches of the adult
mammalian brain (Cheng et al., 2009).
Recently, Yoo et al. (2009) showed that miR-124 and miR-
9 facilitate the conversion of human ﬁbroblasts into neurons
by modifying the subunit composition of the BAF chromatin-
remodeling complex, thereby transforming it into a neuronal
speciﬁc chromatin remodeler. miR-9is highly expressed in mouse
OPCs and targets the 3′UTR of an mRNA encoding peripheral
myelin protein Pmp22 (Figure 2). Together with the inhibition
of astrocytic GFAP, miR-9 may repress expression of non-lineage
related proteins in oligodendrocytes and function as a guardian
to maintain oligodendroglial identity (Krichevsky et al., 2006;
Figure 2). It will be interesting to investigate whether overex-
pression of miR-9 in cooperation with OL-speciﬁc transcription
factors, might also convert ﬁbroblast into oligodendrocyte-like
cells.
CONTROL OF OLIGODENDROCYTE PROLIFERATION BY
miRNAs
As in many other cell types, the initiation of OL differentiation
is very tightly linked to the cessation of OPC proliferation and
cell cycle withdrawal (Temple and Raff, 1985; Barres and Raff,
1994; Raff et al., 1998). However, targeted disruption of cell cycle
components that results in proliferation arrest is often insufﬁcient
to promote the program of OL differentiation (Casaccia-Bonneﬁl
and Liu, 2003). Deletion of Dicer1 gene in oligodendrocyte lineage
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cells induced OPC proliferation, and a drastic reduction in myeli-
nation, suggesting that miRNAs are required for normal OPC cell
cycle exit and differentiation (Dugas et al., 2010; Zhao et al., 2010).
Those two studies, identiﬁed thatmiR-219,miR-138, andmiR-338
may function by targeting OPC-expressed genes whose repression
is necessary topromote the rapid cessationof proliferation coupled
to OL differentiation.
LikemiR-138,miR-219, andmiR-338,miR-17–92miRNA clus-
ter, also known as Oncomir-1, is highly enriched in oligodendro-
cytes (Lau et al., 2008; Budde et al., 2010). Targeted inactivation
of miR-17–92 cluster leads to a reduction in the number of oligo-
dendrocytes, in vivo (Budde et al., 2010). Indeed, expression of the
Oncomir-1 in primary cultures of OPCs promotes cell prolifera-
tion by inﬂuencing Akt signaling (Budde et al., 2010). Consistent
with the role of this miRNA in promoting cell survival (Ventura
et al., 2008), miR-17–92 cluster plays an important role in OPC
survival and proliferation.
On the other hand,miR-192, amiRNAs induced duringOL dif-
ferentiation, has been directly implicated in arresting the cell cycle
by coordinately repressing several G1-S andG2-M cell cycle check-
point control genes (Georges et al., 2008). Another OL-induced
miRNA, miR-181a, functions as a tumor suppressor in gliomas
(Shi et al., 2008).
Recently, by using an elegant mosaic mouse model, Liu et al.
(2011) demonstrated that OPCs are a major cell of origin of
glioma, which might link the role of miRNAs in promoting OL
differentiation by inhibiting OPC proliferation-promoting genes.
Speciﬁcally, if OL-expressedmiRNAs inhibit cellular proliferation,
the loss of these miRNAs could create a permissive environment
for tumorigenesis. In fact, OL-enriched miR-219, miR-138, and
miR-192 are downregulated in brain tumor samples relative to
normal tissue control (Ferretti et al., 2009).
Collectively, these results suggest that miRNAs are essential
in determining oligodendroglial cell number by promoting OPC
cell cycle exit and survival in a temporally speciﬁc fashion.
Indeed, miRNAs may offer novel avenues for future therapeutic
development in CNS tumors.
ROLE OF SPECIFIC miRNAs IN OLIGODENDROCYTE
DIFFERENTIATION
Several groups have performed miRNA microarray proﬁling on
the CNS tissues of wild-type andmyelin deﬁcientDicer1 knockout
mice and identiﬁed a cohort of miRNAs that are downregu-
lated in myelin deﬁcient Dicer1 mutants (Shin et al., 2009; Zhao
et al., 2010). Among them, miR-219 and miR-338 are substan-
tially increased at the onset of oligodendrocyte myelination, and
in mature oligodendrocytes and play a positive role in promot-
ing OPC differentiation. Expression of stable miRNA mimics for
either miR-219 or miR-338-5p and miR-338-3p together can pro-
mote OPC differentiation and partially rescue the differentiation
deﬁcit of Dicer1-deleted OPCs in vitro (Dugas et al., 2010; Zhao
et al., 2010). Overexpression of miR-219 or miR-338 miRNA is
sufﬁcient to promote precocious expression of oligodendrocyte
lineage markers in the developing chick and mouse CNS (Zhao
et al., 2010). Consistently, knock-down of these two miRNAs in
cultured OPCs (Dugas et al., 2010; Zhao et al., 2010) or miR-219
in zebraﬁsh embryos (note that miR-338 is not detectable in the
CNS of zebraﬁsh embryos; Zhao et al., 2010) inhibits OPC differ-
entiation suggesting that miR-219 is both necessary and sufﬁcient
for oligodendrocyte differentiation.
On the other hand, miR-138 exhibits transient expression in
early postmitotic oligodendrocytes. Expression of miR-138 stim-
ulates early differentiation, but inhibits oligodendrocyte terminal
differentiation (Dugas et al., 2010).
FINE-TUNING OLIGODENDROCYTE DIFFERENTIATION
THROUGH TEMPORAL NEGATIVE FEEDBACK LOOPS
miR-219 and miR-338 target a number of genes that have pre-
viously been shown to be involved in inhibiting OPC differenti-
ation and maintaining OPCs in the proliferative state, including
PDGFRα, Hes5, and Sox6 (Dugas et al., 2010; Zhao et al., 2010;
Figure 2). Interestingly, miR-219 may also target other transcrip-
tion factors such as Zfp238, FoxJ3, NeuroD1, Isl1, and Otx2 that
are potentially involved in promoting neurogenesis (Dugas et al.,
2010; Zhao et al., 2010; Figure 2). Since overexpression of these
pro-neural factors is able to inhibit OPC differentiation, miRNA-
mediated inhibition of the factors may restrict differentiation of
neural progenitors to the oligodendrocyte lineage. Together, a net-
work of miRNAs individually or cooperatively regulates distinct
stages of oligodendrocyte lineage progression, as well as safeguards
against the expression of neuronal and other cell lineage genes.
Besides regulating the differentiation program, miR-219 also
regulates a lipid metabolism such as by targeting fatty acid elon-
gase ELOVL7, which synthesizes very long chain of fatty acid
(Figure 2). Accumulation of fatty acids were observed in PLP-
CreERT Dicer-ﬂoxed mice (Shin et al., 2009), suggesting miRNAs
such as miR-219 also play a role in myelin membrane home-
ostasis. Collectively, miRNAs function at multiple stages dur-
ing oligodendrocyte lineage development to direct and ﬁne-tune
oligodendrocyte differentiation processes (Figure 2).
miRNAs IN DEMYELINATING DISEASES
The progressive loss of CNS myelin in patients with MS results
from the combined effects of damage to oligodendrocytes and
remyelination failure. A common feature of the demyelinated
lesions is the presence of OPCs at the premyelinating stage. How-
ever, the mechanistic basis for the impaired myelin repair is not
completely understood. Since MS is heterogeneous with respect
to clinical manifestations and responses to therapy, the identiﬁ-
cation of biomarkers appears desirable for an improved diagnosis
of MS as well as for monitoring of disease activity and treatment
response.
MicroRNA proﬁles have been established from active and inac-
tive demyelinating lesions (Junker et al., 2009) and peripheral
blood cells (Du et al., 2009; Keller et al., 2009; Otaegui et al.,
2009) fromMS patients. Those studies documented differences in
miRNA expression patterns in MS patients compared to healthy
controls as well as in relapse versus remission of the disease. Due
to substantial gliosis and immune cell inﬁltration in demyelinat-
ing lesions, strongly upregulated miRNAs in tissue lesions are
mainly assigned to astrocytes, T cells, andmonocytes (Junker et al.,
2009). Indeed, miRNA proﬁling in isolated cells by laser capture
microdissection from active and inactiveMS lesions shows that the
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upregulated miRNAs in active MS lesions, such as miR-155, miR-
650, miR-34a, and miR-326, are mainly assigned to astrocytes and
inﬁltrating immune cells (Junker et al., 2009). Consistently,Dicer1
ablation in mature OLs results in demyelination and inﬂamma-
tory neuronal degeneration similar to that of MS (Dugas et al.,
2010), suggesting that miRNAs are not only key players dur-
ing development but also during myelin maintenance or disease
formation.
miR-219 and miR-338 are highly expressed in mature oligo-
dendrocytes and their expression is lost when Dicer1 function is
speciﬁcally ablated in mature oligodendrocytes (Shin et al., 2009).
Strikingly, mature OL-enriched miRNAs such as miR-219 and
miR-338 are the least detectable miRNAs in chronic MS lesions
(Junker et al., 2009), suggesting that these miRNAs may also func-
tion in human OL maturation and myelin repair. On the other
hand, since miR-219 and miR-338 are highly expressed in OLs,
the decrease of those miRNAs expression might reﬂect the mature
myelinatingOL loss in theMS plaques. Further studies will be nec-
essary to elucidate the role of those miRNAs in MS pathogenesis
and whether those miRNAs can promote remyelination process.
Other miRNAs such as miRNA-23 may contribute to demyeli-
nating diseases such as adult-onset autosomal dominant leukody-
strophy by targeting lamin B1 (Lin and Fu, 2009). Elevated level of
LaminB1 by gene duplications preferentially leads to myelin loss
in the CNS.
As miRNAs are more stable than mRNAs, they are good can-
didates as disease biomarkers. Moreover, expression of miRNAs
can be detected and quantiﬁed by sensitive luminescence-based,
ﬂuorescence-based and nanotechnology-based methods (Kong
et al., 2009). The use of miRNAs as biomarkers has gained growing
interest in the last few years. Blood serum and plasma are impor-
tant sample types for investigating miRNAs as biomarkers. For
example, Keller et al. (2009) investigated the expression proﬁle of
human miRNAs in whole blood cells of MS patients and found
165 miRNAs signiﬁcantly up- or down-regulated in patients with
relapsing/remitting MS as compared to healthy controls. The best
singlemiRNAmarker,miR-145, allows discriminatingMSpatients
from controls with a speciﬁcity of 89.5%, suggesting that single
miRNA, or a cohort of miRNAs, may have the potential to serve
as diagnostic biomarkers for relapsing/remitting MS.
MicroRNA proﬁling in different demyelinating diseases
to identify miRNAs that reﬂect the fundamental feature of
demyelinating pathology may point to new biomarkers for
demyelinating diseases such as MS. Further functional analyses
of these miRNAs in regulating expression of target mRNAs are
critical to understand their impact on pathogenesis and progress
of the disease.
CONCLUSION
The discovery of miRNAs enables a deeper insight into complex-
ity of gene regulatory networks during the myelination process.
It is clear that understanding OL development in general requires
a deeper appreciation for epigenetic mechanisms that modulate
OL identity, including their interplay with genetic and other cell-
intrinsic factors and cell-extrinsic and cell–cell cues, such as those
derived from the microenvironment. Efforts are underway to col-
lect and analyze the individual components of the entire miRNA
network, and their functional interplay with regulatory circuitry
that controls the myelination program during development and
myelin regeneration after injury.
The functional signiﬁcance of some of these miRNAs is begin-
ning to emerge.miRNAs playmultiple roles at various stages of OL
development, including in the initial production of fate-speciﬁed
OPCs, in the differentiation of matureOLs and generation of com-
pact CNS myelin during development, and in the maintenance of
functional myelin sheaths in adult animals.
Understanding miRNA signatures during development and in
disease states, will be valuable both for diagnostic and therapeu-
tic purposes. miRNAs have an advantage over mRNAs as they are
more stable and do not undergo a signiﬁcant decay during the
tissue sample processing (Jung et al., 2010). The robustness of
proﬁling data suggests that miRNAs are potential biomarkers for
diagnosis or monitoring demyelinating diseases. Further uncov-
ering key functions for miRNAs will illuminate important aspects
in regulating myelination processes. New knowledge about these
small regulatory molecules will offer novel therapeutic interven-
tions by which disease-related miRNAs could be antagonized or
functionally restored for myelin repair. The future challenge will
be to translate this knowledge into improved outcome for patients
with demyelinating diseases.
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